Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Silver-Russell syndrome is characterized by growth retardation with antenatal onset, characteristic facies and limb asymmetry.
Biomarker and diagnostic research for Silver-Russell syndrome has been reported in the published literature.
Estimated prevalence: 1-9 in 1,000,000 (Rare).
2 clinical trials registered, 2 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
68 publications have been identified in PubMed for Silver-Russell syndrome. Research spans Case Report / Case Series (34%), Basic Science / Preclinical (19%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 23 | 34% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Silver-Russell syndrome
Laboratory research |
13 |
19% |
Disease patterns and progression | 11 | 16% |
Research summaries | 9 | 13% |
Testing and diagnosis research | 5 | 7% |
Clinical study results | 5 | 7% |
Other research | 2 | 3% |
Gallardo V (2026). [PMID: 42001697](https://pubmed.ncbi.nlm.nih.gov/42001697/). *Growth Horm IGF Res*. [Review / Meta-Analysis]
Giabicani E (2026). [PMID: 40827087](https://pubmed.ncbi.nlm.nih.gov/40827087/). *The Journal of clinical endocrinology and metabolism*. [Case Report / Case Series]
Muz N (2026). [PMID: 41475895](https://pubmed.ncbi.nlm.nih.gov/41475895/). *Arch Dis Child*. [Epidemiology / Natural History]
Tobar M (2026). [PMID: 42098940](https://pubmed.ncbi.nlm.nih.gov/42098940/). *Am J Med Genet A*. [Case Report / Case Series]
Betoko RM (2026). [PMID: 42237104](https://pubmed.ncbi.nlm.nih.gov/42237104/). *BMC Pediatr*. [Case Report / Case Series]
Świąder-Leśniak A (2026). [PMID: 42163355](https://pubmed.ncbi.nlm.nih.gov/42163355/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Juven A (2026). [PMID: 41997497](https://pubmed.ncbi.nlm.nih.gov/41997497/). *Ann Endocrinol (Paris)*. [Basic Science / Preclinical]
Kooper D (2026). [PMID: 42225318](https://pubmed.ncbi.nlm.nih.gov/42225318/). *BMJ Case Rep*. [Case Report / Case Series]
Perriere A (2026). [PMID: 41697933](https://pubmed.ncbi.nlm.nih.gov/41697933/). *Horm Res Paediatr*. [Clinical Trial Publication]
Lee W (2026). [PMID: 41913935](https://pubmed.ncbi.nlm.nih.gov/41913935/). *J Child Orthop*. [Epidemiology / Natural History]